MR Imaging Measurements of Altered Placental Oxygenation in Pregnancies Complicated by Fetal Growth Restriction

被引:54
|
作者
Ingram, Emma [1 ]
Morris, David [2 ]
Naish, Josephine [2 ]
Myers, Jenny [1 ]
Johnstone, Edward [1 ]
机构
[1] Univ Manchester, St Marys Hosp, Inst Human Dev, Maternal & Fetal Hlth Res Ctr, 5th Floor Res,Oxford Rd, Manchester M13 9WL, England
[2] Univ Manchester, St Marys Hosp, Inst Populat Hlth, Ctr Imaging Sci, 5th Floor Res,Oxford Rd, Manchester M13 9WL, England
关键词
RELAXATION-TIME MEASUREMENTS; MATERNAL HYPEROXIA; BLOOD; PREECLAMPSIA; RETARDATION; STANDARDS; FLUIDS;
D O I
10.1148/radiol.2017162385
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To evaluate oxygen-enhanced and blood oxygen level-dependent (BOLD) magnetic resonance (MR) imaging parameters in normal pregnancies and those complicated by fetal growth restriction (FGR). Materials and Methods: This case-control study was approved by the local research ethics committee. Informed consent was obtained from all subjects. From October 2010 to October 2015, 28 women with uncomplicated pregnancies (individualized birthweight ratio [IBR]> 20th percentile and delivery >37 weeks) and 23 with pregnancies complicated by FGR (IBR <5th percentile and abnormal Doppler ultrasonography [US] studies) underwent MR imaging. Differences in placental longitudinal R1 (1/T1) and transverse R2* (1/T2*) were quantified, with subjects breathing either air or oxygen. The difference in R1 (Delta R1) after hyperoxia was converted to change in partial pressure of oxygen (Delta Po-2). Data were acquired prospectively, with retrospective interpretation of group differences (unpaired t tests). Diagnostic models were developed by using logistic regression analysis with gestational age as a covariate. Results: The mean baseline R1 and R2* for normal pregnancies (R1: 0.59 sec(-1), 95% confidence interval [CI]: 0.58 sec(-1), 0.60 sec(-1); R2*: 17 sec(-1), 95% CI: 14 sec(-1), 20 sec(-1)) were significantly different from those of pregnancies complicated by FGR (R1: 0.63 sec(-1), 95% CI: 0.62 sec(-1), 0.65 sec(-1); R2*: 26 sec(-1), 95% CI: 22 sec(-1), 32 sec(-1)) (P <.0001). The Delta R1 showed a significant negative association with gestational age (P <.0001) in the combined cohort, with the FGR group having a Delta R1 that was generally 61.5% lower than that in the normal pregnancy group (P =.003). The area under the receiver operating characteristic curve for the differentiation between pregnancy complicated by FGR and normal pregnancy by using Delta Po-2, baseline R1, and baseline R2* was 0.91 (95% CI: 0.82, 0.99). Conclusion: R1, R2*, and Delta Po-2 were significantly different between normal pregnancies and those complicated by severe FGR. MR imaging parameters have the potential to help identify placental dysfunction associated with FGR and may have clinical utility in correctly identifying FGR among fetuses that are small for gestational age. A larger prospective study is needed to assess the incremental benefit beyond that offered by US. (C) RSNA, 2017
引用
收藏
页码:953 / 960
页数:8
相关论文
共 50 条
  • [21] Fetal tissue Doppler imaging in pregnancies complicated with preeclampsia with or without intrauterine growth restriction
    Zhou, Qiongjie
    Ren, Yunyun
    Yan, Yingliu
    Chu, Chen
    Gui, Yonghao
    Li, Xiaotian
    PRENATAL DIAGNOSIS, 2012, 32 (11) : 1021 - 1028
  • [22] Placental expression of PlGF and sFlt-1 in pregnancies complicated with preeclampsia with or without fetal growth restriction
    Kappou, D.
    Androutsopoulos, V.
    Papantoniou, N.
    Konstantinidou, A.
    Koutroulakis, D.
    Spandidos, D. A.
    Sifakis, S.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2013, 32 : S83 - S83
  • [23] The impact of placental massive perivillous fibrin deposition on neonatal outcome in pregnancies complicated by fetal growth restriction
    Spinillo, Arsenio
    Gardella, Barbara
    Muscettola, Giulia
    Cesari, Stefania
    Fiandrino, Giacomo
    Tzialla, Chryssoula
    PLACENTA, 2019, 87 : 46 - 52
  • [24] Placental and Fetal Metabolic Reprogramming in Pregnancies with Intrauterine Growth Restriction
    Innocenti, Francesca
    Scaramuzzo, Rosa Teresa
    Lunardi, Federica
    Tosto, Simona
    Pascarella, Francesca
    Calvani, Maura
    Pini, Alessandro
    Filippi, Luca
    REPRODUCTIVE SCIENCES, 2025, 32 (02) : 502 - 513
  • [25] Evaluation of fetal growth restriction in pregnancies complicated by buprenorphine therapy
    Sweeney, Kaitlyn
    Quinn, Shantel
    Young, Amanda J.
    Paglia, Michael J.
    Mackeen, A. Dhanya
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2021, 224 (02) : S714 - S714
  • [26] THE ASSOCIATION OF ANTIPHOSPHOLIPID ANTIBODIES WITH PREGNANCIES COMPLICATED BY FETAL GROWTH RESTRICTION
    POLZIN, WJ
    KOPELMAN, JN
    ROBINSON, RD
    READ, JA
    BRADY, K
    OBSTETRICS AND GYNECOLOGY, 1991, 78 (06): : 1108 - 1111
  • [27] Changes in cell turnover are associatedd with altered expression of oncoproteins in trophoblast of pregnancies complicated by fetal growth restriction
    Heazell, Alexander
    Baker, Philip
    Crocker, Ian
    PLACENTA, 2006, 27 (9-10) : A44 - A44
  • [28] Changes in the Fetal and Neonatal Cytokine Profile in Pregnancies Complicated by Fetal Growth Restriction
    Mullins, Edward
    Prior, Tomas
    Roberts, Irene
    Kumar, Sailesh
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2013, 69 (05) : 441 - 448
  • [29] Pregnancy outcomes in correlation with placental histopathology in pregnancies complicated by fetal growth restriction with vs. without reduced fetal movements
    Mor, Liat
    Rabinovitch, Tamar
    Schreiber, Letizia
    Paz, Yael Ganor
    Barda, Giulia
    Kleiner, Ilia
    Weiner, Eran
    Levy, Michal
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2024, 310 (03) : 1631 - 1637
  • [30] Placental expression of IGF-1 and IGFBP-3 in pregnancies complicated by fetal growth restriction.
    Rolfo, A
    Vasario, E
    Cardaropoli, S
    Piccoli, E
    Todros, T
    JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2006, 13 (02) : 106A - 106A